$ivst showing huge upside for 2019
Top 10 Reasons to Buy IVST
1. 1st stage breakout just completed, IVST is ready for another move
after holding $0.40 support. Full size chart: https://tinyurl.com/y9lbw7xr
2. Grown from $0 revenue to $34M revenue this year
3. LOI on pending acquisition to add $12M in revenue
4. 20% ownership in Stem Vax. StemVax brain tumor vaccine has been
granted patent approval after a nine year filing process
5. First half 2018 revenue growth 55.8%
6. No convertible debts, no warrants or options outstanding
7. Current assets of $877,861; Cash balance of $561,062
8. Winslow Asset Management, the first institutional investor in
Innovest Global, filed showing that they remain a long shareholder
9. Leadership under Dan Martin has been tremendous. Investor Video:
https://www.youtube.com/watch?
10. Shares Outstanding Shares 109M 9/14/18. Float Shares 11.8M 8/16/18
(no changes in over 2 years)
https://www.innovestglobal.com/